Beijing Zhidemai Technology (300785.SZ) shareholder and director Liu Chao collectively reduced holdings by 1.6014 million shares.
(300785.SZ) announcement, the company's shareholder and director Liu Chao will be on leave from April 15, 2023 to...
Beijing Zhidemai Technology (300785.SZ) announced that shareholder and director Liu Chao has reduced his holdings of the company's shares by a total of 1.6014 million shares from April 15, 2023 to January 17, 2025.
Related Articles
IMPACT THERAP-B (07630) plans to repurchase up to HK$100 million of the company's H shares.
Booking (BKNG.US) Q3 total bookings of $54.5 billion beat expectations; adjusted EPS jumps 17%; Q4 guidance turns cautious due to Middle East situation
CMS (00867): Marketing Authorization Application for Innovative Drug Ruxolitinib Phosphate Cream Approved in Singapore
IMPACT THERAP-B (07630) plans to repurchase up to HK$100 million of the company's H shares.
Booking (BKNG.US) Q3 total bookings of $54.5 billion beat expectations; adjusted EPS jumps 17%; Q4 guidance turns cautious due to Middle East situation
CMS (00867): Marketing Authorization Application for Innovative Drug Ruxolitinib Phosphate Cream Approved in Singapore
